Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants' in the study history. The record revision is updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

- Check19 days agoChange DetectedA new page revision (v3.5.5) was added and the previous revision (v3.5.4) was removed. This indicates an update to the history page itself rather than changes to the trial data.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the record history page, signaling a new version of the study record has been posted.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s interface revision was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI.SummaryDifference0.1%

- Check69 days agoChange DetectedThe record history shows a revision bump from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision v3.5.0 was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.